Cumberland Pharmaceuticals (CPIX) Change in Accured Expenses (2010 - 2026)

Cumberland Pharmaceuticals has reported Change in Accured Expenses for 17 years, with the latest figure at -$1.3 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 124.34% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 730.44% YoY) and the FY2025 annual result came in at $6.7 million, up 776.77% from the prior year.
• Change in Accured Expenses retreated to -$1.3 million in Q1 2026 per CPIX's latest filing, from $8.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $8.0 million in Q4 2025 and troughed at -$3.3 million in Q4 2023.
• A 5-year average of $1.0 million and a median of $197393.0 in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses surged 2957.92% in 2022, then plunged 185.82% in 2024.
• Over 5 years, Change in Accured Expenses stood at $5.8 million in 2022, then slumped by 157.46% to -$3.3 million in 2023, then jumped by 90.2% to -$324294.0 in 2024, then soared by 2580.43% to $8.0 million in 2025, then slumped by 116.73% to -$1.3 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.3 million, $8.0 million, and $684224.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.